Pure Global

Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design - Trial NCT05516082

Access comprehensive clinical trial information for NCT05516082 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Recruiting. The study focuses on Ametropia. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05516082
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05516082
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Clinical Evaluation of Two Daily Disposable Lenses in Sphere Design

Study Focus

Ametropia

Lens A

Interventional

device

Sponsor & Location

Coopervision, Inc.

Mexico City, Mexico

Timeline & Enrollment

N/A

Dec 01, 2022

Dec 01, 2022

40 participants

Primary Outcome

Overall Lens Fit Acceptance

Summary

The aim of this study is to evaluate the patient subjective experiences of the daily
 disposable hydrogel lens when compared to the daily disposable silicone hydrogel lens after
 15 minutes of daily wear each.

ICD-10 Classifications

Amblyopia ex anopsia
Amoebiasis
Amoebiasis, unspecified
Myoclonus
Oesophagitis

Data Source

ClinicalTrials.gov

NCT05516082

Device Trial